DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · IEX Real-Time Price · USD
0.661
-0.021 (-3.04%)
At close: Apr 22, 2024, 4:00 PM
0.660
-0.001 (-0.15%)
After-hours: Apr 22, 2024, 5:47 PM EDT
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of $127.19 million as of April 23, 2024. Its market cap has decreased by -61.62% in one year.
Market Cap
127.19M
Enterprise Value
-17.44M
1-Year Change
-61.62%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since October 22, 2014, DBV Technologies's market cap has decreased from $844.80M to $127.19M, a decrease of -84.94%. That is a compound annual growth rate of -18.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2024 | 127.50M | -3.04% |
| Apr 19, 2024 | 131.50M | 3.14% |
| Apr 18, 2024 | 127.50M | -2.75% |
| Apr 17, 2024 | 131.10M | -3.03% |
| Apr 16, 2024 | 135.20M | 0.90% |
| Apr 15, 2024 | 134.00M | 0.15% |
| Apr 12, 2024 | 133.80M | -0.89% |
| Apr 11, 2024 | 135.00M | -2.81% |
| Apr 10, 2024 | 138.90M | -1.91% |
| Apr 9, 2024 | 141.60M | -4.65% |
| Apr 8, 2024 | 148.50M | - |
| Apr 5, 2024 | 148.50M | 10.00% |
| Apr 4, 2024 | 135.00M | -6.64% |
| Apr 3, 2024 | 144.60M | -1.97% |
| Apr 2, 2024 | 147.50M | -1.93% |
| Apr 1, 2024 | 150.40M | 4.08% |
| Mar 28, 2024 | 144.50M | -2.30% |
| Mar 27, 2024 | 147.90M | -1.20% |
| Mar 26, 2024 | 149.70M | -1.12% |
| Mar 25, 2024 | 151.40M | -1.37% |
| Mar 22, 2024 | 153.50M | -0.52% |
| Mar 21, 2024 | 154.30M | -1.22% |
| Mar 20, 2024 | 156.20M | 1.76% |
| Mar 19, 2024 | 153.50M | 3.37% |
| Mar 18, 2024 | 148.50M | -2.56% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Karyopharm Therapeutics | 136.27M |
| Repare Therapeutics | 132.87M |
| MSP Recovery | 132.69M |
| Omega Therapeutics | 132.37M |
| Vaxart | 131.37M |
| VistaGen Therapeutics | 128.64M |
| Sagimet Biosciences | 127.97M |
| Amylyx Pharmaceuticals | 126.75M |